130 related articles for article (PubMed ID: 10234883)
1. [Effects of chemical mixtures on embryonic development: examples of experimental models and problems in risk assessment].
Ricciardi C; Macrì C; Maranghi F; Stazi AV; Mantovani A
Ann Ist Super Sanita; 1998; 34(4):519-27. PubMed ID: 10234883
[TBL] [Abstract][Full Text] [Related]
2. A new frontier in understanding the mechanisms of developmental abnormalities.
Kimmel CA; Generoso WM; Thomas RD; Bakshi KS
Toxicol Appl Pharmacol; 1993 Apr; 119(2):159-65. PubMed ID: 7683149
[TBL] [Abstract][Full Text] [Related]
3. Future of toxicology--low-dose toxicology and risk--benefit analysis.
Rietjens IM; Alink GM
Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
[TBL] [Abstract][Full Text] [Related]
4. Integrated approaches for the analysis of toxicologic interactions of chemical mixtures.
el-Masri HA; Reardon KF; Yang RS
Crit Rev Toxicol; 1997 Mar; 27(2):175-97. PubMed ID: 9099518
[TBL] [Abstract][Full Text] [Related]
5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
6. [New aspects in the evaluation of risk factors for fetal development].
Mantovani A; Stazi AV; Bernardini G; Broccia ML; Nuccetelli C; Pagano G; Settimi L; Tiboni GM
Ann Ist Super Sanita; 1999; 35(2):153-63. PubMed ID: 10645648
[TBL] [Abstract][Full Text] [Related]
7. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
Brent RL
Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
[TBL] [Abstract][Full Text] [Related]
8. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
Brent RL
Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
[TBL] [Abstract][Full Text] [Related]
9. Significance of excursions of intake above the acceptable daily intake: effect of time and dose in developmental toxicology.
Sullivan FM
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S94-8. PubMed ID: 10597620
[TBL] [Abstract][Full Text] [Related]
10. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of cumulative risk of mixtures with multiple target organs].
Galli CL; Marinovich M
G Ital Med Lav Ergon; 2003; 25(3):328-9. PubMed ID: 14582250
[TBL] [Abstract][Full Text] [Related]
12. Behavioral toxicology in risk assessment: problems and research needs.
Mitchell CL; Tilson HA
Crit Rev Toxicol; 1982 Oct; 10(4):265-74. PubMed ID: 6756792
[TBL] [Abstract][Full Text] [Related]
13. [Potential role of hormesis in risk assessment in occupational toxicology].
Iavicoli I; Carelli G
G Ital Med Lav Ergon; 2003; 25 Suppl(3):174-5. PubMed ID: 14979136
[TBL] [Abstract][Full Text] [Related]
14. Binary weight-of-evidence evaluations of chemical interactions--15 years of experience.
Pohl HR; Mumtaz MM; Scinicariello F; Hansen H
Regul Toxicol Pharmacol; 2009 Aug; 54(3):264-71. PubMed ID: 19445993
[TBL] [Abstract][Full Text] [Related]
15. Deciding which chemical mixtures risk assessment methods work best for what mixtures.
Teuschler LK
Toxicol Appl Pharmacol; 2007 Sep; 223(2):139-47. PubMed ID: 16997340
[TBL] [Abstract][Full Text] [Related]
16. Exposure to multiple environmental agents and their effect.
Koppe JG; Bartonova A; Bolte G; Bistrup ML; Busby C; Butter M; Dorfman P; Fucic A; Gee D; van den Hazel P; Howard V; Kohlhuber M; Leijs M; Lundqvist C; Moshammer H; Naginiene R; Nicolopoulou-Stamati P; Ronchetti R; Salines G; Schoeters G; ten Tusscher G; Wallis MK; Zuurbier M
Acta Paediatr Suppl; 2006 Oct; 95(453):106-13. PubMed ID: 17000577
[TBL] [Abstract][Full Text] [Related]
17. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
19. Experimental and mathematical modeling methods for the investigation of toxicological interactions.
El-Masri HA
Toxicol Appl Pharmacol; 2007 Sep; 223(2):148-54. PubMed ID: 16996550
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment of endocrine disrupters: the role of toxicological studies.
Mantovani A
Ann N Y Acad Sci; 2006 Sep; 1076():239-52. PubMed ID: 17119206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
